ONYX-II: Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Coadministered with Ribavirin in Asian Adults with Genotype 1b Chronic Hepatitis C Virus Infection and Compensated Cirrhosis

被引：0
|
作者：
Wei, Lai [1 ]
Wang, Qui-Qiang [2 ]
Luo, Yan [3 ]
Chu, Chi-Jen [4 ]
Paik, Seung Woon [5 ]
Hou, Jinlin [6 ]
Cheng, Jun [7 ]
Xie, Qing [8 ]
Duan, Zhongping [9 ]
Kao, Jia-Horng [10 ]
Fu, Bo [3 ]
Mobashery, Niloufar [3 ]
Heo, Jeong [11 ,12 ]
机构：
[1] Peking Univ, Peoples Hosp, Beijing, Peoples R China
[2] Peking Univ, Hosp 1, Beijing, Peoples R China
[3] AbbVie Inc, N Chicago, IL USA
[4] Taipei Vet Gen Hosp, Taipei, Taiwan
[5] Samsung Med Ctr, Seoul, South Korea
[6] Southern Med Univ, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China
[7] Capital Med Univ, Beijing Di Tan Hosp, Beijing, Peoples R China
[8] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai, Peoples R China
[9] Capital Med Univ, Beijing Youan Hosp, Beijing, Peoples R China
[10] Natl Taiwan Univ Hosp, Zhongzheng Dist, Taiwan
[11] Pusan Natl Univ, Coll Med, Dept Internal Med, Busan, South Korea
[12] Pusan Natl Univ Hosp, Med Res Inst, Busan, South Korea
来源：
HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
875
引用
收藏
页码：434A / 434A
页数：1
相关论文
共 50 条
  • [41] Population pharmacokinetics of paritaprevir, ombitasvir, dasabuvir, ritonavir and ribavirin in hepatitis C virus genotype 1 infection: analysis of six phase III trials
    Mensing, Sven
    Eckert, Doerthe
    Sharma, Shringi
    Polepally, Akshanth R.
    Khatri, Amit
    Podsadecki, Thomas J.
    Awni, Walid M.
    Menon, Rajeev M.
    Dutta, Sandeep
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (03) : 527 - 539
  • [42] Population Pharmacokinetics of Paritaprevir, Ombitasvir, and Ritonavir in Japanese Patients with Hepatitis C Virus Genotype 1b Infection
    Gopalakrishnan, Sathej M.
    Polepally, Akshanth R.
    Mensing, Sven
    Khatri, Amit
    Menon, Rajeev M.
    CLINICAL PHARMACOKINETICS, 2017, 56 (01) : 1 - 10
  • [43] Population Pharmacokinetics of Paritaprevir, Ombitasvir, and Ritonavir in Japanese Patients with Hepatitis C Virus Genotype 1b Infection
    Sathej M. Gopalakrishnan
    Akshanth R. Polepally
    Sven Mensing
    Amit Khatri
    Rajeev M. Menon
    Clinical Pharmacokinetics, 2017, 56 : 1 - 10
  • [44] Population Pharmacokinetics of Paritaprevir, Ombitasvir, Dasabuvir, Ritonavir, and Ribavirin in Patients with Hepatitis C Virus Genotype 1 Infection: Combined Analysis from 9 Phase 1b/2 Studies
    Sven Mensing
    Akshanth R. Polepally
    Denise König
    Amit Khatri
    Wei Liu
    Thomas J. Podsadecki
    Walid M. Awni
    Rajeev M. Menon
    Sandeep Dutta
    The AAPS Journal, 2016, 18 : 270 - 280
  • [45] Efficacy and safety of paritaprevir/ritonavir, ombitasvir and dasabuvir plus ribavirin for treatment of HCV genotype lb compensated cirrhosis in patients aged 65 years or older
    Trifan, Anca
    Cijevschi, Cristina
    Gheorghe, Liana
    Curescu, Manuela G.
    Brisc, Ciprian
    Bataga, Simona
    Rogoveanu, Ion
    Miftode, Egidia
    Arama, Victoria
    Chiriac, Stefan
    Sporea, Ioan
    Goldis, Adrian
    Popescu, Alina
    Cojocariu, Camelia
    Stefanescu, Gabriela V.
    Mihai, Catalina
    Ciortescu, Irina
    Stanciu, Carol
    HEPATOLOGY, 2016, 64 : 997A - 998A
  • [46] Population Pharmacokinetics of Paritaprevir, Ombitasvir, Dasabuvir, Ritonavir, and Ribavirin in Patients with Hepatitis C Virus Genotype 1 Infection: Combined Analysis from 9 Phase 1b/2 Studies
    Mensing, Sven
    Polepally, Akshanth R.
    Koenig, Denise
    Khatri, Amit
    Liu, Wei
    Podsadecki, Thomas J.
    Awni, Walid M.
    Menon, Rajeev M.
    Dutta, Sandeep
    AAPS JOURNAL, 2016, 18 (01): : 270 - 280
  • [47] Outcome of patients with compensated liver cirrhosis with hepatitis B virus plus hepatitis C virus coinfection treated with paritaprevir/ombitasvir/ritonavir, dasabuvir with ribavirin: a national cohort study
    Preda, C.
    Popescu, C.
    Constantinescu, I.
    Manuc, M.
    Tugui, L.
    Voiosu, R.
    Ceausu, E.
    Diculescu, M.
    Oproiu, A.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S295 - S296
  • [48] Ombitasvir/paritaprevir/ritonavir plus dasabuvir plus ribavirin for chronic hepatitis C virus genotype 1b-infected cirrhotics (TURQUOISE-IV)
    Isakov, Vasily
    Paduta, Dzmitry
    Viani, Rolando M.
    Enejosa, Jeffrey V.
    Pasechnikov, Viktor
    Znoyko, Olga
    Ogurtsov, Pavel
    Bogomolov, Pavel O.
    Maevskaya, Marina V.
    Chen, Xiaotian
    Shulman, Nancy S.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 30 (09) : 1073 - 1076
  • [49] Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65years with HCV genotype 1 cirrhosis
    Ascione, Antonio
    De Luca, Massimo
    Melazzini, Mario
    Montilla, Simona
    Trotta, Maria Paola
    Petta, Salvatore
    Puoti, Massimo
    Sangiovanni, Vincenzo
    Messina, Vincenzo
    Bruno, Savino
    Izzi, Antonio
    Villa, Erica
    Aghemo, Alessio
    Zignego, Anna Linda
    Orlandini, Alessandra
    Fontanella, Luca
    Gasbarrini, Antonio
    Marzioni, Marco
    Giannini, Edoardo G.
    Craxi, Antonio
    INFECTION, 2018, 46 (05) : 607 - 615
  • [50] EFFECTIVENESS AND SAFETY OF OMBITASVIR, PARITAPREVIR, RITONAVIR AND DASABUVIR PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C VIRUS INFECTION: RESULTS FROM THE SPANISH REALWORLD COHORT
    Calleja, J. L.
    Rincon, D.
    Ruiz-Antoran, B.
    Sacristan, B.
    Perello, C.
    Lens, S.
    Fernanadez, I.
    Gea, F.
    Morillas, R. M.
    Cabezas, J.
    Pascasio, J. M.
    Prieto, M.
    Turnes, J.
    Serra, M. A.
    Arenas, J.
    Torras, X.
    Bonet, L.
    Fernandez, C.
    Samaniego, J.
    Hernandez-Albujar, A.
    Ampuero, J.
    Moreno, J. M.
    Saez-Royuela, F.
    Alvarez-Navascues, C.
    Diago, M.
    Sanchez-Antolin, G.
    de la Vega, J.
    Sanchez-Ruano, J. J.
    Andrade, R.
    Butti, M.
    Carrion, J. A.
    Molina, E.
    Simon, M. A.
    Salcines, J. R.
    Jorquera, F.
    Montoliu, S.
    Ahumada, A.
    Hernaez, T.
    Crespo, J.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S218 - S219
12345